First-in-human Phase I studies of PRS-080#22, a hepcidin antagonist, in healthy volunteers and patients with chronic kidney disease undergoing hemodialysis

Thumbnail
Fulltext:
203013.pdf
Size:
1.280Mb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
2019
Author(s)
Renders, L.
Budde, K.
Rosenberger, C.
Swelm, R.P. van
Swinkels, D.W.
Dellanna, F.
Feuerer, W.
Wen, M.
Erley, C.
Bader, B.
Sommerer, C.
Schaier, M.
Meurer, K.
Matis, L.
Source
PLoS One, 14, 3, (2019), article e0212023
ISSN
DOI
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/203013   https://hdl.handle.net/2066/203013
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.